Michel Krempf

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès et al. · Nature Genetics · 2003 · 3K citations

Life Sciences, Genetics, Molecular Genetics +10

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Jennifer G. Robinson, Michel Farnier, Michel Krempf et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients

Lars Sjöström, Aila Rissanen, Teis Andersen et al. · The Lancet · 1998 · 1.2K citations

Agriculture, Nutrition, Nutritional Sciences +14

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

John J.P. Kastelein, Henry N. Ginsberg, Gisle Langslet et al. · European Heart Journal · 2015 · 534 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17